Perceptive Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-178,797
Closed -$9.13M 115
2024
Q4
$9.13M Buy
+178,797
New +$8.79M 0.25% 65
2022
Q4
Sell
-70,000
Closed -$5.08M 112
2022
Q3
$5.08M Buy
+70,000
New +$5.21M 0.15% 81
2022
Q2
Sell
-30,000
Closed -$2.72M 129
2022
Q1
$2.72M Buy
+30,000
New +$2.46M 0.05% 113
2021
Q3
Sell
-310,437
Closed -$29M 159
2021
Q2
$29M Sell
310,437
-254,676
-45% -$24.7M 0.38% 61
2021
Q1
$60.5M Sell
565,113
-103,387
-15% -$10.7M 0.76% 36
2020
Q4
$58.4M Sell
668,500
-180,000
-21% -$12.7M 0.63% 40
2020
Q3
$58.6M Buy
848,500
+152,500
+22% +$9.81M 0.86% 32
2020
Q2
$33.7M Buy
+696,000
New +$33.2M 0.55% 45

Other funds holding NARI

Perceptive Advisors's NARI Position: Q1 2025 in Review

Perceptive Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 178,797 shares — an estimated $9.13M sold.

Perceptive Advisors first reported a position in NARI in Q2 2020 and held it in 8 quarters. The position peaked at $60.5M in Q1 2021. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Perceptive Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Perceptive Advisors sold 178,797 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $9.13M.
  • Perceptive Advisors first reported a position in Inari Medical, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
  • Perceptive Advisors's Inari Medical, Inc. Common Stock position peaked at $60.5M in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Perceptive Advisors's 13F filing for Q1 2025, filed 15 May 2025.